Rivers J K
Division of Dermatology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Skin Therapy Lett. 2004 Jan;9(1):1-3.
Actinic Keratoses (AKs) are epidermal skin lesions that have the potential to develop into squamous cell carcinoma. Many of the treatment options available can cause discomfort, pain or skin irritation. Topical 3% diclofenac in 2.5% hyaluronan gel (Solaraze, Bioglan Pharma) is a relatively new treatment that has been shown to be effective and well tolerated for the treatment of AKs.
光化性角化病（AKs）是一种表皮皮肤病变，有发展成鳞状细胞癌的可能。现有的许多治疗方法会引起不适、疼痛或皮肤刺激。含2.5%透明质酸凝胶的3%双氯芬酸局部用药（Solaraze，Bioglan制药公司）是一种相对较新的治疗方法，已被证明对治疗光化性角化病有效且耐受性良好。
